Mitochondrial involvement in non-alcoholic steatohepatitis

Area of Science:

• Hepatology
• Mitochondrial Biology
• Metabolic Diseases

Background:

• Non-alcoholic steatohepatitis (NASH) is a progressive liver disease linked to increasing prevalence.
• Mitochondrial dysfunction is a consistent hallmark across NASH etiologies.
• Mitochondria regulate fatty acid metabolism and cellular energy balance, crucial for hepatocyte function.

Purpose of the Study:

• To review the role of mitochondria in fat metabolism and energy homeostasis in NASH.
• To focus on mitochondrial impairment and uncoupling proteins in NASH pathophysiology.
• To discuss potential therapeutic strategies targeting mitochondrial function.

Main Methods:

• Literature review focusing on mitochondrial roles in NASH.
• Analysis of the interplay between mitochondrial respiratory chain, UCP2, and redox balance.
• Discussion of drug effects on mitochondrial function in NASH.

Main Results:

• Mitochondrial dysfunction impairs fatty liver homeostasis and promotes oxidative stress (ROS production).
• Impaired mitochondria lead to lipid peroxidation, cytokine release, and cell death.
• A cooperative pathway involving the respiratory chain, UCP2, and redox balance is proposed for fat removal and oxidative damage limitation.

Conclusions:

• Mitochondrial dysfunction is a critical driver of NASH progression to cirrhosis.
• Hepatocytes struggle to maintain ATP stores under high energy supply, exacerbating steatosis.
• Targeting mitochondrial function presents a promising therapeutic avenue for NASH treatment.